Liling Warren

3.2k total citations
26 papers, 1.6k citations indexed

About

Liling Warren is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Liling Warren has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Liling Warren's work include Genetic Associations and Epidemiology (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Drug-Induced Adverse Reactions (3 papers). Liling Warren is often cited by papers focused on Genetic Associations and Epidemiology (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Drug-Induced Adverse Reactions (3 papers). Liling Warren collaborates with scholars based in United States, United Kingdom and Japan. Liling Warren's co-authors include Eden R. Martin, Stephanie A. Monks, Norman Kaplan, Eric Lai, Allen D. Roses, Arlene R. Hughes, Michael Mosteller, William Spreen, Jeffery M. Vance and Brandon D. Slotterbeck and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Nature Reviews Genetics.

In The Last Decade

Liling Warren

24 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liling Warren United States 15 507 497 281 251 193 26 1.6k
David A. Katz United States 27 236 0.5× 1.1k 2.1× 191 0.7× 424 1.7× 150 0.8× 64 3.4k
Ramesh C. Juyal India 23 499 1.0× 470 0.9× 251 0.9× 233 0.9× 59 0.3× 51 1.5k
Joseph S. Dillon United States 29 280 0.6× 621 1.2× 457 1.6× 395 1.6× 104 0.5× 75 2.7k
Masanobu Yamada Japan 31 437 0.9× 1.1k 2.3× 251 0.9× 231 0.9× 39 0.2× 208 3.7k
Michael Pike United Kingdom 24 385 0.8× 459 0.9× 616 2.2× 152 0.6× 30 0.2× 61 1.9k
Takehira Yamamura Japan 26 535 1.1× 551 1.1× 99 0.4× 158 0.6× 53 0.3× 104 2.7k
Stephen Donoghue United Kingdom 18 703 1.4× 541 1.1× 83 0.3× 441 1.8× 138 0.7× 35 2.6k
Sirui Zhou China 24 504 1.0× 640 1.3× 235 0.8× 242 1.0× 28 0.1× 84 1.8k
Klaus Lindpaintner United States 27 1.1k 2.2× 901 1.8× 50 0.2× 433 1.7× 173 0.9× 61 2.5k
Heike Bickeböller Germany 25 450 0.9× 780 1.6× 102 0.4× 196 0.8× 35 0.2× 94 2.0k

Countries citing papers authored by Liling Warren

Since Specialization
Citations

This map shows the geographic impact of Liling Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Warren more than expected).

Fields of papers citing papers by Liling Warren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liling Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Warren. The network helps show where Liling Warren may publish in the future.

Co-authorship network of co-authors of Liling Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Liling Warren. A scholar is included among the top collaborators of Liling Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liling Warren. Liling Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doyle, Philip C., Marco Guevara, Anthony J. Perkins, et al.. (2024). A Randomized Controlled Crossover Trial to Evaluate the Efficacy of AI-Assisted Heart Contouring. International Journal of Radiation Oncology*Biology*Physics. 120(2). S41–S41.
2.
Petrova, Ralitsa, Abhijeet R. Patil, Minoti Bhakta, et al.. (2023). Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB. Scientific Reports. 13(1). 16699–16699. 4 indexed citations
3.
Patil, Abhijeet R., Gaurav Kumar, Huanyu Zhou, & Liling Warren. (2023). scViewer: An Interactive Single-Cell Gene Expression Visualization Tool. Cells. 12(11). 1489–1489. 5 indexed citations
4.
Lariosa‐Willingham, Karen, Dmitri Leonoudakis, Kendall R. Walker, et al.. (2023). Imiquimod-induced pruritus in female wild-type and knockin Wistar rats: underscoring behavioral scratching in a rat model for antipruritic treatments. BMC Research Notes. 16(1). 348–348. 1 indexed citations
5.
Yeo, Astrid, Liling Warren, Jennifer L. Aponte, et al.. (2017). Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib. PLoS ONE. 12(7). e0182115–e0182115. 15 indexed citations
6.
Ziauddeen, Hisham, Liam J. Nestor, Naresh Subramaniam, et al.. (2016). Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. Neuropsychopharmacology. 41(11). 2647–2657. 15 indexed citations
7.
Xu, Chun‐Fang, Toby Johnson, Xiaojing Wang, et al.. (2015). HLA-B *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer. Clinical Cancer Research. 22(6). 1371–1377. 70 indexed citations
8.
Ziauddeen, Hisham, Pradeep J. Nathan, Chris Dodds, et al.. (2013). The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu‐opioid receptor antagonist GSK1521498 in healthy subjects. The Journal of Clinical Pharmacology. 53(10). 1078–1090. 10 indexed citations
9.
Rubio, Justin P., Simon Topp, Liling Warren, et al.. (2012). Deep sequencing of theLRRK2gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. Human Mutation. 33(7). 1087–1098. 24 indexed citations
10.
Hughes, Arlene R., William Spreen, Michael Mosteller, et al.. (2008). Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility. The Pharmacogenomics Journal. 8(6). 365–374. 61 indexed citations
11.
Hulihan, Mary, Jennifer M. Kachergus, Liling Warren, et al.. (2008). LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study. The Lancet Neurology. 7(7). 591–594. 120 indexed citations
12.
Hulihan, Mary, Jennifer M. Kachergus, Ruchi Upmanyu, et al.. (2008). PINK1 mutations and parkinsonism. Neurology. 71(12). 896–902. 41 indexed citations
13.
Zhu, Guohua, Liling Warren, Jennifer L. Aponte, et al.. (2007). The SERPINE2 Gene is Associated with Chronic Obstructive Pulmonary Disease in Two Large Populations. American Journal of Respiratory and Critical Care Medicine. 176(2). 167–173. 97 indexed citations
14.
Warren, Liling, Rachel A. Gibson, Lianna Ishihara, et al.. (2007). A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism & Related Disorders. 14(1). 77–80. 31 indexed citations
15.
Spraggs, Colin F., Alun D. McCarthy, Linda McCarthy, et al.. (2007). Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar. Pharmacogenetics and Genomics. 17(12). 1065–1076. 11 indexed citations
16.
Ishihara, Lianna, Liling Warren, Rachel A. Gibson, et al.. (2006). Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations. Archives of Neurology. 63(9). 1250–1250. 74 indexed citations
17.
Hughes, Arlene R., Michael Mosteller, Aruna T. Bansal, et al.. (2004). Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics. 5(2). 203–211. 185 indexed citations
18.
Martin, Eden R., Stephanie A. Monks, Liling Warren, & Norman Kaplan. (2000). A Test for Linkage and Association in General Pedigrees: The Pedigree Disequilibrium Test. The American Journal of Human Genetics. 67(1). 146–154. 435 indexed citations
19.
Martin, Eden R., Eric Lai, John R. Gilbert, et al.. (2000). SNPing Away at Complex Diseases: Analysis of Single-Nucleotide Polymorphisms around APOE in Alzheimer Disease. The American Journal of Human Genetics. 67(2). 383–394. 287 indexed citations
20.
Martin, Eden R., John R. Gilbert, Eric Lai, et al.. (2000). Analysis of Association at Single Nucleotide Polymorphisms in the APOE Region. Genomics. 63(1). 7–12. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026